Location: Home
  • search
  • go
  • Relate News
  • 3/18/2021NMPA Revises Packages Inserts of Sodium Ferulate for Injection
  • 3/18/2021Ping An Good Doctor: Cross-Sectional Survey
  • 3/17/2021Pfizer To Be Granted Priority Review for Its NDA of Abrocitinib
  • 3/17/2021NHSA Releases Its 2020 Healthcare Security Sector Development Statisti...
  • 3/17/2021Daewoong Pharma Signs $338M Deal Licensing Out Fexuprazan to Yangtze ...
  • 3/16/2021AVEO Reclaims Full Global Rights to Antibody Drug from CANbridge
  • 3/16/2021CDE Issues the Technical Requirements for Topical Dermatological Gener...
  • 3/16/2021NHC Solicits Comments on the draft Provisions for Ethical Review of Li...
  • 3/16/2021Snapshot of 11 Domestic Class 1 New Drugs Approved in China Last Year
  • 3/16/2021Snapshot of Biological Product Registration and Launch in China Last Y...
  • 3/16/2021Chinese Chemical Drug Manufacturing Industry Revenue Down Slightly in ...
  • 3/16/2021Italfarmaco Group Agreed with Luye Pharma to Commercialize Rivastigmi...
  • 3/16/2021Pfizer to Halt Biosimilar Production in China and Sell Its Hangzhou Bi...
  • 3/16/2021Remegen Wins China Approval for Lupus Drug Telitacicept
  • 3/16/2021BeiGene Announces Acceptance of a Supplemental Biologics License Appli...
  • 3/16/2021Teva CEO Talks About Risks in Excessive Reliance on China for APIs
  • 3/16/2021China Approves Another COVID-19 Vaccine for Emergency Use
  • 3/16/2021Patent Term Extension in China
  • 3/15/2021NMPA Announces OTC Switch of Miconazole Nitrate Vaginal Tablets
  • 3/15/2021NHC Issues the 2nd Batch of Its List of Encouraged Generic Drugs
  • 3/15/2021Highlights of the 14th Five Year Plan Covers Various Aspects of Health...
  • 3/12/2021CDE Issues the Guidelines for Acceptance and Evaluation of TCM Changes
  • 3/12/2021Recent Executive Moves
  • 3/12/2021CDE Issues the Technical Guidelines for Pharmaceutical Changes During ...
  • 3/12/2021NHC Issues the Pediatric Vaccine Inoculation Procedures and Notes of t...
  • 3/11/2021Bayer's Chinese NDA for PI3K Inhibitor Copanlisib Accepted by the CDE
  • 3/11/2021NHSA Initiates DRG-based Medical Insurance Payment in Simulation Run
  • 3/11/2021NMPA Publicizes the List of Reference Formulations for GQCE Studies (4...
  • 3/10/2021Alphamab's IND for Phase II Pivotal Trial of KN046 Cleared in the U.S...
  • 3/10/2021Eirion Therapeutics Closes $40M Series A Investment and Licensing Deal...
  • Page:195/775 Total number of articles:23222: [First][<<] [193] [194] [195] [196] [197] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group